Pharmacodynamic Evaluation of Syzygium Cumini Extract in Experimental Diabetic Models

The experimental analysis of Syzygium cumini extract pharmacodynamic properties examines blood glucose control mechanisms and antioxidant effects and tests security parameters. For 28 days Wistar rats with streptozotocin-induced diabetes received Syzygium cumini extract treatment at both 200 mg/kg and 400 mg/kg doses. Blood glucose levels decreased substantially during the study period while the high-dose treatment group achieved near-normal glucose concentrations by its conclusion. The antioxidant function of the extract occurred due to elevated reduced glutathione (GSH) together with higher superoxide dismutase (SOD), catalase levels and decreased malondialdehyde (MDA). Tests of lipid profile showed higher HDL values and lower levels of total cholesterol and triglycerides and LDL which could protect the heart. The test of liver enzymes validated a good safety profile for the extract because it yielded negative hepatotoxicity results. Test outcomes demonstrate that Syzygium cumini extract may function as an additional treatment to manage diabetes together with its connected complications and protect the cardiovascular system.